ArticleBlood advances2017
Hispanic ethnicity is associated with younger age at presentation but worse survival in acute myeloid leukemia.
Article in Blood advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 16 citations in OpenAlex.
- Impact of race on mutational profile and survival in acute myeloid leukemia: a single-institution experience (2014-2024).Annals of hematology · 2026Article
- Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia.Haematologica · 2026Article
- Impact of demographic factors on clinical outcomes of patients with acute myeloid leukemia.Haematologica · 2026Article
- Real-world treatment outcomes from a retrospective cohort of patients with acute myeloid leukemia from an urban safety net hospital.Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2025Article
- Cytogenetic and Molecular Characteristics in Adult Hispanic Acute Myeloid Leukemia Patients From Puerto Rico.Cureus · 2024Article
- Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia.EJHaem · 2022Article
- Blood cancer health disparities in the United States Hispanic population.Cold Spring Harbor molecular case studies · 2021Article
- Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico.Oncotarget · 2020Article
- A Qualitative Study of the Initial Diagnosis and Treatment Experience of Black Patients with Newly Diagnosed Acute Myeloid Leukemia.Palliative medicine reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 3 institutions in 1 country.
Funding
Abstract
SEER data and a Bronx validation cohort demonstrate that Hispanics present with AML at younger age but have shorter survival than whites.Increased frequency of high-risk mutations in Hispanics provides a potential biologic explanation for poorer outcomes in Hispanics.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.